Luis Hernandez

8PUBLICATIONS
14CO-AUTHORS
PharmacogenomicsRespiratory diseasesArchitectural computing and visualisation methodsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 27, 2026
Disease Burden, Inadequate Hematocrit Control, and Thromboembolic Events in Patients with Polycythemia Vera Despite Current Standard of Care Treatment: A Retrospective Claims Study.

|Jun 03, 2026
Burden of thromboembolism, disease progression, and phlebotomy among polycythemia vera patients in the United States: a systematic literature review.

|Aug 12, 2024
The maze of real-world evidence frameworks: from a desert to a jungle! An environmental scan and comparison across regulatory and health technology assessment agencies.

Grammati Sarri, Luis G Hernandez

|Aug 05, 2024
Budget impact analysis of introducing fruquintinib for metastatic colorectal cancer previously treated with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy and biologics in the United States from the payer perspective.

Victoria Federico Paly, Shujun Li, Pratishtha Khanduri

|Jul 08, 2024
Adverse event costs of systemic therapies for metastatic colorectal cancer previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy and biologics in the US.

Victoria Federico Paly, Arvind Dasari, Joleen Hubbard

|Jun 25, 2024
A Systematic Review of Modeling Approaches to Evaluate Treatments for Relapsed Refractory Multiple Myeloma: Critical Review and Considerations for Future Health Economic Models.

Andreas Freitag, Grammati Sarri, An Ta

Pageof 2

Frequent Collaborators

2 joint publications

Grammati Sarri

2 joint publications

Victoria Federico Paly

1 joint publications

Maria Rizzo

1 joint publications

Pratishtha Khanduri